Gut Microbiota Therapy in Gastrointestinal Diseases

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2025 Mar 13

PMID 40078367

Authors

Hanif Ullah

Safia Arbab

Chengting Chang

Saira Bibi

Nehaz Muhammad

Sajid Ur Rehman

Suleman

Irfan Ullah

Inam Ul Hassan

Yali Tian

Ka Li

Affiliations

Soon will be listed here.

Abstract

The human gut microbiota, consisting of trillions of microorganisms, plays a crucial role in gastrointestinal (GI) health and disease. Dysbiosis, an imbalance in microbial composition, has been linked to a range of GI disorders, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, and colorectal cancer. These conditions are influenced by the interactions between the gut microbiota, the host immune system, and the gut-brain axis. Recent research has highlighted the potential for microbiome-based therapeutic strategies, such as probiotics, prebiotics, fecal microbiota transplantation (FMT), and dietary modifications, to restore microbial balance and alleviate disease symptoms. This review examines the role of gut microbiota in the pathogenesis of common gastrointestinal diseases and explores emerging therapeutic approaches aimed at modulating the microbiome. We discuss the scientific foundations of these interventions, their clinical effectiveness, and the challenges in their implementation. The review underscores the therapeutic potential of microbiome-targeted treatments as a novel approach to managing GI disorders, offering personalized and alternative options to conventional therapies. As research in this field continues to evolve, microbiome-based interventions hold promise for improving the treatment and prevention of gastrointestinal diseases.

References

Willett W, Stampfer M, Colditz G, Rosner B, Speizer F . Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med. 1990; 323(24):1664-72. DOI: 10.1056/NEJM199012133232404. View

Hold G, Smith M, Grange C, Watt E, El-Omar E, Mukhopadhya I . Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?. World J Gastroenterol. 2014; 20(5):1192-210. PMC: 3921503. DOI: 10.3748/wjg.v20.i5.1192. View

Guerra-Valle M, Orellana-Palma P, Petzold G . Plant-Based Polyphenols: Anti- Effect and Improvement of Gut Microbiota. Antioxidants (Basel). 2022; 11(1). PMC: 8772845. DOI: 10.3390/antiox11010109. View

Tsoi H, Chu E, Zhang X, Sheng J, Nakatsu G, Ng S . Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology. 2017; 152(6):1419-1433.e5. DOI: 10.1053/j.gastro.2017.01.009. View

Schrezenmeir J, de Vrese M . Probiotics, prebiotics, and synbiotics--approaching a definition. Am J Clin Nutr. 2001; 73(2 Suppl):361S-364S. DOI: 10.1093/ajcn/73.2.361s. View

Flowers S, Ellingrod V . The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management. Pharmacotherapy. 2015; 35(10):910-6. DOI: 10.1002/phar.1640. View

Pushalkar S, Hundeyin M, Daley D, Zambirinis C, Kurz E, Mishra A . The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018; 8(4):403-416. PMC: 6225783. DOI: 10.1158/2159-8290.CD-17-1134. View

Philips C, Augustine P, Ganesan K, Ranade S, Chopra V, Patil K . The role of gut microbiota in clinical complications, disease severity, and treatment response in severe alcoholic hepatitis. Indian J Gastroenterol. 2022; 41(1):37-51. DOI: 10.1007/s12664-021-01157-9. View

Derosa L, Routy B, Thomas A, Iebba V, Zalcman G, Friard S . Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 2022; 28(2):315-324. PMC: 9330544. DOI: 10.1038/s41591-021-01655-5. View

10.

Wang W, Shi L, Shi L, Xu L . [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease]. Zhonghua Nei Ke Za Zhi. 2018; 57(2):101-106. DOI: 10.3760/cma.j.issn.0578-1426.2018.02.004. View

11.

. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

12.

Kelly C, Zheng L, Campbell E, Saeedi B, Scholz C, Bayless A . Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe. 2015; 17(5):662-71. PMC: 4433427. DOI: 10.1016/j.chom.2015.03.005. View

13.

Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W . Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019; 178(4):795-806.e12. PMC: 7288240. DOI: 10.1016/j.cell.2019.07.008. View

14.

Reynolds A, Paterson J, Ferguson S, Stanley D, Wright Jr K, Dawson D . The shift work and health research agenda: Considering changes in gut microbiota as a pathway linking shift work, sleep loss and circadian misalignment, and metabolic disease. Sleep Med Rev. 2016; 34:3-9. DOI: 10.1016/j.smrv.2016.06.009. View

15.

Shen X, Rawls J, Randall T, Burcal L, Mpande C, Jenkins N . Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes. 2010; 1(3):138-47. PMC: 2927011. DOI: 10.4161/gmic.1.3.12360. View

16.

Ma Y, Zhang Y, Xiang J, Xiang S, Zhao Y, Xiao M . Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer. Front Cell Infect Microbiol. 2021; 11:599734. PMC: 7962608. DOI: 10.3389/fcimb.2021.599734. View

17.

Burnet P, Cowen P . Psychobiotics highlight the pathways to happiness. Biol Psychiatry. 2013; 74(10):708-9. DOI: 10.1016/j.biopsych.2013.08.002. View

18.

Cryan J, ORiordan K, Sandhu K, Peterson V, Dinan T . The gut microbiome in neurological disorders. Lancet Neurol. 2019; 19(2):179-194. DOI: 10.1016/S1474-4422(19)30356-4. View

19.

Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M . The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014; 6(263):263ra158. PMC: 4396848. DOI: 10.1126/scitranslmed.3009759. View

20.

Shanahan F . Probiotics in perspective. Gastroenterology. 2010; 139(6):1808-12. DOI: 10.1053/j.gastro.2010.10.025. View